| 产品编号 | CFN60032 | |
| CAS编号 | 391210-10-9 | |
| 分子式 = 分子量 | C16H14F3IN2O4 = 482.19 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| PD0325901(Mirdametinib) | CFN60032 | 391210-10-9 | 1mg | QQ客服:1413575084 |
| PD0325901(Mirdametinib) | CFN60032 | 391210-10-9 | 5mg | QQ客服:1413575084 |
| PD0325901(Mirdametinib) | CFN60032 | 391210-10-9 | 10mg | QQ客服:1413575084 |
| PD0325901(Mirdametinib) | CFN60032 | 391210-10-9 | 20mg | QQ客服:1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM in cell-free assays, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. |
| Targets: | MEK | ERK1/ERK2 |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.0739 mL | 10.3694 mL | 20.7387 mL | 41.4774 mL | 51.8468 mL |
| 5 mM | 0.4148 mL | 2.0739 mL | 4.1477 mL | 8.2955 mL | 10.3694 mL |
| 10 mM | 0.2074 mL | 1.0369 mL | 2.0739 mL | 4.1477 mL | 5.1847 mL |
| 50 mM | 0.0415 mL | 0.2074 mL | 0.4148 mL | 0.8295 mL | 1.0369 mL |
| 100 mM | 0.0207 mL | 0.1037 mL | 0.2074 mL | 0.4148 mL | 0.5185 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 13-脱氧-10-O-乙基-8-羟基延命素; Serrin A | CFN96677 | 845959-98-0 | C22H30O6 = 390.47 | 5mg | QQ客服:2056216494 |
| 麦角硫因; L-(+)-Ergothioneine | CFN91629 | 497-30-3 | C9H15N3O2S = 229.3 | 20mg | QQ客服:3257982914 |
| Cyclocerberidol; Cyclocerberidol | CFN99376 | 126594-66-9 | C9H16O4 = 188.2 | 5mg | QQ客服:2159513211 |
| N-苯基咔唑; 9-Phenylcarbazole | CFN90113 | 1150-62-5 | C18H13N = 243.30 | 5mg | QQ客服:3257982914 |